fashion -WSS

fashion

author：Wikipedia 2025-09-28 05:04:30 - browse：9319

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cancer, immunology, HIV research ensnared in fetal tissue politics

leisure time

WSS

Medical experts exlpore how to eliminate bias in clinical algorithms

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Chinese researcher claims birth of first gene

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Surgeons perform first xenotransplant using CRISPR'd pig kidney

focus

fashion

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cancer, immunology, HIV research ensnared in fetal tissue politics

United colonoscopy coverage change 'may cost lives,' doctors say

Illumina to lay off 10% of research and development team

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Supreme Court rules employers must be more accommodating of religious observance

BioMarin wins approval for gene therapy to treat hemophilia A

Erich Jarvis studies song birds to learn about human stuttering

In Memoriam: Notable people who died in 2023

Synthetic human embryos? Researchers say term is overblown

Wikipedia

Bring on the sabbaticals for nurses

The strange history of BMI, the body mass index

Medical experts exlpore how to eliminate bias in clinical algorithms

GOP inquiry over gain

With Wegovy coverage, Medicare patients may face high costs

Ukrainian soldiers say they owe lives to US

entertainment

hotspot

leisure time

explore